Fructose-1,6-bisphosphatase as a therapeutic target for type 2 diabetes: from molecular mechanisms to clinical translation.

Joshi P, Mazumder A, Pentela B, Debnath A

Open source

DOI
10.1080/13813455.2026.2706204
Published
2026 Aug 6
Container
Archives of physiology and biochemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/13813455.2026.2706204,
  title = {Fructose-1,6-bisphosphatase as a therapeutic target for type 2 diabetes: from molecular mechanisms to clinical translation.},
  author = {Joshi P and Mazumder A and Pentela B and Debnath A},
  year = {2026},
  journal = {Archives of physiology and biochemistry},
  doi = {10.1080/13813455.2026.2706204},
  url = {https://doi.org/10.1080/13813455.2026.2706204}
}

RIS

TY  - JOUR
TI  - Fructose-1,6-bisphosphatase as a therapeutic target for type 2 diabetes: from molecular mechanisms to clinical translation.
AU  - Joshi P
AU  - Mazumder A
AU  - Pentela B
AU  - Debnath A
PY  - 2026
JO  - Archives of physiology and biochemistry
DO  - 10.1080/13813455.2026.2706204
UR  - https://doi.org/10.1080/13813455.2026.2706204
ER  - 

APA

P, J., A, M., B, P., & A, D. (2026). Fructose-1,6-bisphosphatase as a therapeutic target for type 2 diabetes: from molecular mechanisms to clinical translation.. Archives of physiology and biochemistry. https://doi.org/10.1080/13813455.2026.2706204

Source records